fda retatrutide β οΈ Before you consider using retatrutide, know the facts. has not completed the approval process, there is no official assessment confirming its safety or quality. The risks are real: π« FDA warns against unapproved drugs
Description
Probst et al
We identified genetic proxies of the effect of GLP-1R, GIPR, and GCGR agonists by combining MR, Bayesian colocalization, and linkage disequilibrium (LD) analyses
She also serves on committees for the North American Neuromodulation Society

in recent years, given benefits promoting weight loss
